Day Forty
May has begun with a low key announcement of extending the lockdown by further 2 weeks till 17th. This will be a mirage in the absence of a clear criteria for lifting lockdown. In USA, CDC has given a guideline that once a region experiences a 14-day decline in the hospitalisation rate they may begin a phased re-opening.
FDA is likely to fast track its approval of Remdesivir. Much hope riding now on this drug from Gilead. The trials so far have demonstrated 30% shortening of the recovery time for COVID19 patients.
Comments
Post a Comment